Circulating Tumor Cells and the CellSearch Assay

April 2011

Dr. Halling will provide an overview of the metastatic process in cancer and how circulating tumor cell counts influence prognosis and overall survival in metastatic breast, colorectal, or prostate cancer.

Mr. Campion will discuss the technical aspects of a novel assay for enumerating circulating tumor cells in peripheral blood and cite several clinical trial studies describing the clinical utility of this assay.

Presenters:

• Kevin Halling, MD, PhD of the Division of Laboratory Genetics
• Michael Campion of the Division of Laboratory Genetics

Print Options

• Before viewing, print the Notes Pages.
• After viewing, obtain a Record of Viewing.

Related Tests

• Circulating Tumor Cells (CTC) for Breast Cancer by CellSearch, Blood
• Circulating Tumor Cells (CTC) for Colorectal Cancer by CellSearch, Blood
• Circulating Tumor Cells (CTC) for Prostate Cancer by CellSearch, Blood

Forward to a Colleague

Share this presentation with:

• Oncologists
• Urologists
• Gastroenterologists
• Women’s Health Physicians

If you have questions, e-mail